As of July 2026, 166 paid clinical trials are recruiting for Oncology in Denver, Colorado. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Denver has approximately 515 recruiting research studies across a wide range of therapeutic areas. Colorado hosts the University of Colorado Anschutz Medical Campus, National Jewish Health, and Children's Hospital Colorado, with strong programs in pulmonology, oncology, and cardiovascular research.
Researchers run research studies in Denver, CO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Colorado Blood Cancer Institute | Multiple Myeloma, Non-Hodgkin Lymphoma, Acute Myeloid Leukemia | 47 |
| National Jewish Health | Cystic Fibrosis, Pulmonary Hypertension, Asthma | 42 |
| Sarah Cannon Research Institute at HealthONE | Advanced Solid Tumor, Solid Tumor, Carcinoma | 29 |
| Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Metastatic Osteosarcoma | 18 |
| Rocky Mountain Cancer Centers | Breast Cancer, Colorectal Neoplasms, Breast Neoplasms | 17 |
| Kaiser Permanente-Franklin | Breast Carcinoma, Anatomic Stage II Breast Cancer AJCC v8, Colorectal Carcinoma | 15 |
| UCHealth - Cherry Creek | Anatomic Stage II Breast Cancer AJCC v8, Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 | 13 |
| University of Colorado | B Cell Lymphoma, B-Cell Non-Hodgkin's Lymphoma, CADASIL | 13 |
| Denver Health Medical Center | Acute Respiratory Failure, Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder) | 11 |
| Presbyterian - Saint Lukes Medical Center - Health One | Anatomic Stage IV Breast Cancer AJCC v8, Malignant Solid Neoplasm, Acral Lentiginous Melanoma | 10 |
| Rocky Mountain Cancer Centers-Midtown | Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Malignant Solid Neoplasm | 10 |
| Rocky Mountain Cancer Centers-Rose | Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Malignant Solid Neoplasm | 10 |
| University of Colorado Denver | Amyotrophic Lateral Sclerosis, Attention, Behavioral Variant Frontotemporal Dementia (bvFTD) | 10 |
| Rocky Mountain Cancer Centers, LLP | Colorectal Neoplasms, Urothelial Cancer, Advanced Renal Cell Carcinoma | 9 |
| Denver Health and Hospital Authority | Sepsis, ARDS, Acute Otitis Media | 9 |
| Children's Hospital Colorado | ALL, AML, Acute Respiratory Distress Syndrome | 9 |
| The Women's Imaging Center | Anatomic Stage IV Breast Cancer AJCC v8, Malignant Solid Neoplasm, Acral Lentiginous Melanoma | 9 |
| AdventHealth Porter | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 7 |
| Saint Joseph Hospital - Cancer Centers of Colorado | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 7 |
| National Jewish Health-Main Campus | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 6 |
| Sarah Cannon Research Institute | Gastric Cancer, Locally Advanced or Metastatic Solid Tumors, Pancreatic Cancer | 6 |
| Children's Hospital of Colorado | Adolescent, Bowel Incontinence, CBL Syndrome | 6 |
| Denver Health | Angina, Stable, Cardiovascular Diseases, Communication Disabilities | 5 |
| Mountain View Clinical Research | Major Depressive Disorder, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant | 5 |
| Cancer Center of Colorado at Sloan's Lake | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 4 |
Recruiting trials in Denver grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Colorado are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Colorado trials are additionally subject to the Colorado Privacy Act (CPA), which adds consumer data-protection requirements to federal baseline standards.
Hipa.ai aggregates every recruiting study in Denver from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 515 recruiting clinical trials in Denver, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Denver compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Denver include Breast Cancer (18), Advanced Solid Tumor (15), Multiple Myeloma (15), Ovarian Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Denver on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Denver include Colorado Blood Cancer Institute, National Jewish Health, Sarah Cannon Research Institute at HealthONE, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Denver are Cancer & tumors (223), Cardiovascular (14), Diabetes & metabolic (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.